Kolesar J - Search Results

1

Olaparib for the treatment of BRCA-mutated advanced ovarian cancer.

Munroe M, Kolesar J. Munroe M, et al. Among authors: kolesar j. Am J Health Syst Pharm. 2016 Jul 15;73(14):1037-41. doi: 10.2146/ajhp150550. Am J Health Syst Pharm. 2016. PMID: 27385701 Review.

2

Novel approaches to anemia associated with cancer and chemotherapy.

Kolesar JM. Kolesar JM. Am J Health Syst Pharm. 2002 Aug 1;59(15 Suppl 4):S8-11. doi: 10.1093/ajhp/59.suppl_4.S8. Am J Health Syst Pharm. 2002. PMID: 12166035 Review.

3

Role of adjuvant chemotherapy in the treatment of non-small-cell lung cancer.

Wilhelm L, Kolesar JM. Wilhelm L, et al. Am J Health Syst Pharm. 2005 Jul 1;62(13):1365-9. doi: 10.2146/ajhp040529. Am J Health Syst Pharm. 2005. PMID: 15972378 Clinical Trial.

4

Azacitidine: a novel agent for myelodysplastic syndromes.

Sullivan M, Hahn K, Kolesar JM. Sullivan M, et al. Am J Health Syst Pharm. 2005 Aug 1;62(15):1567-73. doi: 10.2146/ajhp040385. Am J Health Syst Pharm. 2005. PMID: 16030365 Review.

5

Role of trastuzumab in adjuvant therapy for locally invasive breast cancer.

Kabe KL, Kolesar JM. Kabe KL, et al. Am J Health Syst Pharm. 2006 Mar 15;63(6):527-33. doi: 10.2146/ajhp050400. Am J Health Syst Pharm. 2006. PMID: 16522889 Review.

6

Pharmacogenetics and irinotecan therapy.

Hahn KK, Wolff JJ, Kolesar JM. Hahn KK, et al. Among authors: kolesar jm. Am J Health Syst Pharm. 2006 Nov 15;63(22):2211-7. doi: 10.2146/ajhp060155. Am J Health Syst Pharm. 2006. PMID: 17090741 Review.

7

Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors.

Utecht KN, Hiles JJ, Kolesar J. Utecht KN, et al. Among authors: kolesar j. Am J Health Syst Pharm. 2006 Dec 1;63(23):2340-8. doi: 10.2146/ajhp060080. Am J Health Syst Pharm. 2006. PMID: 17106006 Review.

8

Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.

Dobbe E, Gurney K, Kiekow S, Lafferty JS, Kolesar JM. Dobbe E, et al. Am J Health Syst Pharm. 2008 Jan 1;65(1):23-8. doi: 10.2146/ajhp060352. Am J Health Syst Pharm. 2008. PMID: 18159035 Review.

9

Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma.

Hiles JJ, Kolesar JM. Hiles JJ, et al. Among authors: kolesar jm. Am J Health Syst Pharm. 2008 Jan 15;65(2):123-31. doi: 10.2146/ajhp060661. Am J Health Syst Pharm. 2008. PMID: 18192256 Review.

10

A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer.

LoConte NK, Thomas JP, Alberti D, Heideman J, Binger K, Marnocha R, Utecht K, Geiger P, Eickhoff J, Wilding G, Kolesar J. LoConte NK, et al. Among authors: kolesar j. Cancer Chemother Pharmacol. 2008 Dec;63(1):109-15. doi: 10.1007/s00280-008-0719-5. Epub 2008 Mar 6. Cancer Chemother Pharmacol. 2008. PMID: 18322686 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters